The Media Lamentations and Press Bereavement Over the Demise of Stephen Colbert Thankfully...
Paige Cognetti Has a History of Harming Scranton Families, and She'd Do the...
Rep. Hageman Channels the Wyoming Way on Energy, Natural Resources Issues
Why I Will Always Stand With Law Enforcement
Student Activists Are a Symptom — Classroom Bias Is the Disease
States Are Not Bystanders in Homeland Defense
Equal Protection Means What It Says
Has Blaine Luetkemeyer Slayed the Corporate DEI Dragons?
Piers Morgan, Ben Gvir, and the Gift Nobody Asked for
Kansas Mom Says School Let Sex Offender Chaperone Field Trip
Man Allegedly Bilked Taxpayers for 20 Years Out of $283k by Stealing Dead...
Memorial Day Weekend Could Mark Next Chapter in U.S.-Iran Conflict
Man Accused of Michigan Shooting Was Previously Convicted of Hog-Tying Woman but Was...
Explosion at Staten Island Shipyard Injures 16
Fake IRS Agent Sentenced to 4 Years in $1.8M Fraud Scheme
OPINION

Despite Delta Fears, Stay-At-Home Stocks Struggle

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
Despite Delta Fears, Stay-At-Home Stocks Struggle
AP Photo/Eugene Hoshiko

Wednesday was another solid session for cyclical names, particularly Materials (XLB) on movement with infrastructure. However, after a strong bond auction, the session got an extra boost, which says foreigner demand pushed yields lower.

Advertisement

To see the chart, click here.


Sector Watch

Keep an eye on Materials - to rally to form a double top -a breakout there would be monumental and spark a much higher move.


Industrials ,also sporting an intriguing chart, has come on strong. The sector has significantly underperformed the S&P over the past six months.


Internals Still Lousy

Market breadth was strong on the New York Stock Exchange (NYSE), reflecting a shift to value, quality, and cyclical names, while the NASDAQ Composite struggled in all measures.

Market Breadth

NYSE

NASDAQ

Advancing

2,205

2,319    

Declining

1,084

2,024

52 Week High

180

144

52 Week Low

34

117

Up Volume

2.30B

2.13B

Down Volume

1.18B

1.75B

FDA Booster Shot

The U.S. Food and Drug Administration (FDA) is ready to authorize a Covid-19 booster shot. Perhaps that’s why so-called stay-at-home or work-from-home names took it on the chin. And reopening stocks found buyers even with elevated Delta variant cases and increased hospitalizations.

Advertisement

Portfolio Approach

We took profits in Healthcare this morning in our Hotline Model Portfolio.

Inflation Picture / Core PPI

For the fifth month in a row, PPI core has come in much hotter than Wall Street consensus – this time twice the consensus of +0.5% - matching the second highest number ever. 

Producer prices continued marching higher – climbing 7.8% from 7.3% - hitting the higher level ever (data kept since Nov 2010).

Lots of noise in the PPI report we need to comb through…but the bias remains to the upside.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement